Healthy At Home, Inc Location: 77 Northeastern Blvd, Nashua, New Hampshire 3062 Ratings: Phone: (603) 595-4243 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide |
Bell Tower Home Health Location: 3 Pine Street Ext K, Nashua, New Hampshire 3063 Ratings:NA Phone: (603) 821-7421 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Comfort Angels Home Care Of Nh, Llc Location: 1 Chestnut St Ste 337, Nashua, New Hampshire 3060 Ratings:NA Phone: (603) 864-8229 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
New Hope Health Solutions, Llc Location: 169 Daniel Webster Highway Ste 104, Nashua, New Hampshire 3060 Ratings:NA Phone: (603) 402-4198 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
A new gene suspected to contribute to autoimmune diseases such as type 1 diabetes and lupus - a condition in which the body's own immune system attacks organs such as the kidneys and skin - has been discovered by Australian National University (ANU) immunologists.
Fertility procedures such as in vitro fertilization (IVF) require a couple and the doctor to place the risky bet that the multiple eggs they choose to fertilize will produce an embryo that will thrive in the uterus. Researchers cannot biopsy eggs directly because that would destroy them, but a new discovery by professors at Brown University and Women & Infants Hospital could lead to new insights about how eggs develop and ultimately inform judgments about how the embryos they produce will fare. The idea is to examine the genetic material the egg cells discarded when they were first forming, to see which genes they were expressing.
A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis.
Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol.
Today's headlines include reports from yesterday's action in an Atlanta courtroom where oral arguments were held in an appeal related to the multi-state challenge to the health law.
› Verified 6 days ago